Inicio › Mieloma múltiple › Carolina del Norte › Winston-Salem
Ensayos clínicos de Mieloma múltiple en Winston-Salem, NC
14 estudios para Mieloma múltiple buscan participantes en centros de Winston-Salem y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
ReclutandoFase 3
- Research Site, Winston-Salem
- Research Site, Winston-Salem
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
ReclutandoFase 2
- Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
ReclutandoFase 2
- Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutandoFase 3
- Novant Health Forsyth Medical Center, Winston-Salem
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
ReclutandoFase 1/2
- Wake Forest Baptist Health /ID# 271294, Winston-Salem
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
ReclutandoFase 3
- Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutandoFase 3
- Research Site, Winston-Salem
- Research Site, Winston-Salem
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
ReclutandoFase 1/2
- Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
ReclutandoFase 1
- Wake Forest University Health Sciences, Winston-Salem
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
ReclutandoFase 3
- GSK Investigational Site, Winston-Salem
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
ReclutandoEstudio observacional
- Wake Forest Baptist Health, Winston-Salem
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutandoFase 1/2
- Atrium Wake Forest Baptist Medical Center, Winston-Salem
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
ReclutandoFase 1/2
- Atrium Health Wake Forest Baptist, Winston-Salem
Más información sobre Mieloma múltiple en MedlinePlus
Ensayos de Mieloma múltiple en otras ciudades
- New York City, NY60 estudios
- Boston, MA42 estudios
- Atlanta, GA42 estudios
- Houston, TX38 estudios
- Durham, NC37 estudios
- Nashville, TN32 estudios
- Denver, CO27 estudios
- Rochester, MN24 estudios
- St. Louis, MO24 estudios
- Columbus, OH24 estudios
- Baldwin Park, CA23 estudios
- Chicago, IL22 estudios
Otros estudios en Winston-Salem
- Cáncer (todos los tipos)19 estudios
- Leucemia mielógena aguda18 estudios
- Cáncer de seno14 estudios
- Enfermedad cardiovascular14 estudios
- Cáncer de pulmón de células no pequeñas12 estudios
- Enfermedad de obstrucción pulmonar crónica10 estudios
- Cáncer de ovario10 estudios
- Diabetes tipo 29 estudios
- Síndromes mielodisplásicos9 estudios
- Glioblastoma8 estudios
- Leucemia linfocítica crónica8 estudios
- Cáncer de pulmón8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.